A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Clinical trial NCT05571839 · TERMINATED

Trial details

NCT number: NCT05571839
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma Non-small Cell Lung Cancer Colorectal Neoplasms Pancreatic Neoplasms Mesothelioma

Start date: 2023-01-03
Primary completion: 2026-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.